These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8345001)

  • 1. Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension.
    Bourget P; Duhamel JF; Sørensen H; Roiron R
    J Clin Pharm Ther; 1993 Jun; 18(3):171-7. PubMed ID: 8345001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation.
    Taburet AM; Guibert J; Kitzis MD; Sorensen H; Acar JF; Singlas E
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():23-31. PubMed ID: 2312443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers.
    Munkholm P; Hey H; Rasmussen SN; Johansen PB
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):337-41. PubMed ID: 7737235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.
    Bulitta JB; Okusanya OO; Forrest A; Bhavnani SM; Clark K; Still JG; Fernandes P; Ambrose PG
    Antimicrob Agents Chemother; 2013 Jan; 57(1):498-507. PubMed ID: 23147726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.
    Macgowan AP; Greig MA; Andrews JM; Reeves DS; Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):593-6. PubMed ID: 16312548
    [No Abstract]   [Full Text] [Related]  

  • 6. Fusidic acid pharmacology, pharmacokinetics and pharmacodynamics.
    Turnidge J
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S23-34. PubMed ID: 10528784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.
    Simon MW; Fish DN; Deeter RG
    Drugs R D; 2002; 3(6):365-73. PubMed ID: 12516939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.
    MacGowan AP; Greig MA; Andrews JM; Reeves DS; Wise R
    J Antimicrob Chemother; 1989 Mar; 23(3):409-15. PubMed ID: 2732122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.
    Peter JD; Jehl F; Pottecher T; Dupeyron JP; Monteil H
    Antimicrob Agents Chemother; 1993 Mar; 37(3):501-6. PubMed ID: 8460918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either haemodialysis or continuous ambulatory peritoneal dialysis.
    Brown NM; Reeves DS; McMullin CM
    J Antimicrob Chemother; 1997 Jun; 39(6):803-9. PubMed ID: 9222051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of fusidic acid in laboratory animals.
    Findon G; Miller TE; Rowe LC
    Lab Anim Sci; 1991 Oct; 41(5):462-5. PubMed ID: 1666148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disposition of sodium fusidate in man.
    Wise R; Pippard M; Mitchard M
    Br J Clin Pharmacol; 1977 Oct; 4(5):615-9. PubMed ID: 911608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sodium fusidate and fusidic acid in dosage forms by high-performance liquid chromatography and a microbiological method.
    Hikal AH; Shibl A; El-Hoofy S
    J Pharm Sci; 1982 Nov; 71(11):1297-8. PubMed ID: 7175730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmacokinetics of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension.
    Thyssen A; Solanki B; Treem W
    Clin Ther; 2012 Jul; 34(7):1636-45. PubMed ID: 22748970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
    Bagli M; Rao ML; Höflich G; Kasper S; Langer M; Barlage U; Beneke M; Süverkrüp R; Möller HJ
    Arzneimittelforschung; 1996 Mar; 46(3):247-50. PubMed ID: 8901143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
    Kearns GL; Young RA
    Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An experimental evaluation of the pharmacokinetics of fusidic acid in peritoneal dialysis.
    Rowe L; Findon G; Miller TE
    J Med Microbiol; 1992 Feb; 36(2):71-7. PubMed ID: 1740786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.